Estatísticas para COVID-19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS-CoV-2 Infection Among Target Groups in Europe, October 2024-January 2025, VEBIS Primary Care Network
Total de visitas
| views | |
|---|---|
| COVID-19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS-CoV-2 Infection Among Target Groups in Europe, October 2024-January 2025, VEBIS Primary Care Network | 7 |
Total de visitas por mês
| views | |
|---|---|
| agosto 2025 | 0 |
| setembro 2025 | 0 |
| outubro 2025 | 0 |
| novembro 2025 | 0 |
| dezembro 2025 | 0 |
| janeiro 2026 | 7 |
| fevereiro 2026 | 0 |
Downloads
| views | |
|---|---|
| Influenza Resp Viruses - 2025 - Laniece Delaunay - COVID‐19 Vaccine Effectiveness Against Medically Attended Symptomatic.pdf | 10 |
Top de consultas por país
| views | |
|---|---|
| Portugal | 6 |
| Estados Unidos | 1 |
Top de consultas por cidade
| views | |
|---|---|
| Braga | 6 |
| Los Angeles | 1 |